Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588874 · ClinicalTrials.gov registry record
Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 24
- Enrollment target
NCT00588874: Completed study, sponsored by Yale University.
NCT00588874 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588874 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to generate preliminary data regarding the skeletal effects of age-related changes in calcium and vitamin D metabolism in older men.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2000-10-01 |
| Est. Completion | 2008-12-01 |
What the finished NCT00588874 record still lists
NCT00588874 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00588874 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00588874 about?
NCT00588874 is a clinical study titled "Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis". The purpose of this pilot study is to generate preliminary data regarding the skeletal effects of age-related changes in calcium and vitamin D metabolism in older men.
What is the current status of trial NCT00588874?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2000-10-01. Estimated completion is 2008-12-01.
Who is sponsoring clinical trial NCT00588874?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI